Burkina Faso vs Mozambique: Total official development assistance to medical research and basic
Burkina Faso
241.5
in 2024
Mozambique
226.35
in 2024
Burkina Faso rank
10th
Mozambique rank
13th
Total official development assistance to medical research and basic over time
- Burkina Faso
- Mozambique
How they compare
Burkina Faso currently reports 241.5 against 226.35 in Mozambique, a difference of 15.15.
That makes Burkina Faso's figure about 1.1 times Mozambique's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Mozambique ahead.
Burkina Faso ranks 10th and Mozambique ranks 13th of 157 countries.
Mozambique has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 116.62 | 228.72 | 112.1 | Mozambique |
| 2020s | 194.34 | 260.8 | 66.46 | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher total official development assistance to medical research and basic, Burkina Faso or Mozambique?
- Burkina Faso, at 241.5 against 226.35 in Mozambique as of 2024.
- What is the difference in total official development assistance to medical research and basic between Burkina Faso and Mozambique?
- 15.15, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Mozambique?
- 15 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Mozambique rank globally for total official development assistance to medical research and basic?
- Burkina Faso ranks 10th and Mozambique ranks 13th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Total official development assistance to medical research and basic health sectors, net disbursement, by recipient countries (millions of constant 2024 United States dollars). Statizoid refreshes it automatically from the source and publishes the full history for both places.